Anne-Marie Hinds1,2, Dorothy A Thompson2, Sohaib R Rufai2, Kelly Weston3, Kemmy Schwiebert2, Vasiliki Panteli2, Greg James4, Richard Bowman5. 1. Department of Paediatric Ophthalmology, Moorfields Eye Hospital, London, United Kingdom. 2. Clinical and Academic Department of Ophthalmology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom. 3. Department of Ophthalmology, Surrey and Sussex Healthcare NHS Trust, Trust Headquarters, East Surrey Hospital, Surrey, United Kingdom. 4. Craniofacial Unit, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom. 5. Clinical and Academic Department of Ophthalmology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom. Richard.Bowman@gosh.nhs.uk.
Abstract
OBJECTIVE: To determine visual outcomes and prevalence of amblyogenic risk factors in children with Apert, Crouzon, Pfeiffer and Saethre-Chotzen syndromes. METHODS: We conducted a single-centre, retrospective chart review of patients assessed at our unit between October 2000 and May 2017. Our outcome measures were as follows: age at first and last examination, refraction, horizontal ocular alignment, alphabet pattern deviations, anterior segment appearance, fundus examination findings, visual evoked potentials (VEPs) and genetics. The study's primary endpoint was the proportion of children achieving best-corrected visual acuity (BCVA) ≥ 6/12 in the better eye at final visit, as per UK driving standards. RESULTS: 165 patients were included in this study. Breakdown of diagnoses was as follows: Crouzon (n = 60), Apert (n = 57), Pfeiffer (n = 14) and Saethre-Chotzen (n = 34). 98 patients were male. Of 133 patients with full BCVA data available, 76.7% achieved BCVA ≥ 6/12 in the better eye. Of 122 patients, anisometropia >1.00 dioptre sphere (DS) affected 18.9% and astigmatism ≥1.00DS in at least one eye affected 67.2%. Of 246 eyes, 48.4% had oblique astigmatism. Of 165 patients, 60 had exotropia and 12 had esotropia. 48 of 99 patients demonstrated 'V' pattern. On multivariable logistic regression, nystagmus (p = 0.009) and ON involvement (p = 0.001) were associated with decreased vision in the worse eye. Normal VEPs were associated with better BCVA (p = 0.036). CONCLUSION: There was a high prevalence of amblyogenic factors, however, the majority achieved BCVA ≥ 6/12 in their better eye. Optic neuropathy and nystagmus had the most significant impact on vision. VEPs can help the in overall assessment of visual function.
OBJECTIVE: To determine visual outcomes and prevalence of amblyogenic risk factors in children with Apert, Crouzon, Pfeiffer and Saethre-Chotzen syndromes. METHODS: We conducted a single-centre, retrospective chart review of patients assessed at our unit between October 2000 and May 2017. Our outcome measures were as follows: age at first and last examination, refraction, horizontal ocular alignment, alphabet pattern deviations, anterior segment appearance, fundus examination findings, visual evoked potentials (VEPs) and genetics. The study's primary endpoint was the proportion of children achieving best-corrected visual acuity (BCVA) ≥ 6/12 in the better eye at final visit, as per UK driving standards. RESULTS: 165 patients were included in this study. Breakdown of diagnoses was as follows: Crouzon (n = 60), Apert (n = 57), Pfeiffer (n = 14) and Saethre-Chotzen (n = 34). 98 patients were male. Of 133 patients with full BCVA data available, 76.7% achieved BCVA ≥ 6/12 in the better eye. Of 122 patients, anisometropia >1.00 dioptre sphere (DS) affected 18.9% and astigmatism ≥1.00DS in at least one eye affected 67.2%. Of 246 eyes, 48.4% had oblique astigmatism. Of 165 patients, 60 had exotropia and 12 had esotropia. 48 of 99 patients demonstrated 'V' pattern. On multivariable logistic regression, nystagmus (p = 0.009) and ON involvement (p = 0.001) were associated with decreased vision in the worse eye. Normal VEPs were associated with better BCVA (p = 0.036). CONCLUSION: There was a high prevalence of amblyogenic factors, however, the majority achieved BCVA ≥ 6/12 in their better eye. Optic neuropathy and nystagmus had the most significant impact on vision. VEPs can help the in overall assessment of visual function.
Authors: Tien Tay; Frank Martin; Neil Rowe; Kim Johnson; Michael Poole; Kimberley Tan; Ian Kennedy; Mark Gianoutsos Journal: Clin Exp Ophthalmol Date: 2006-07 Impact factor: 4.207
Authors: Dorothy A Thompson; Alki Liasis; Sharon Hardy; Richard Hagan; Richard D Hayward; Robert D Evans; Kanwal K Nischal Journal: Plast Reconstr Surg Date: 2006-07 Impact factor: 4.730
Authors: Martijn Cornelissen; Bianca den Ottelander; Dimitris Rizopoulos; René van der Hulst; Aebele Mink van der Molen; Chantal van der Horst; Hans Delye; Marie-Lise van Veelen; Gouke Bonsel; Irene Mathijssen Journal: J Craniomaxillofac Surg Date: 2016-07-12 Impact factor: 2.078
Authors: Suzanne K Jadico; David A Young; Alexandra Huebner; Jane C Edmond; Avrum N Pollock; Donna M McDonald-McGinn; Yi-Ju Li; Elaine H Zackai; Terri L Young Journal: J AAPOS Date: 2006-12 Impact factor: 1.220
Authors: Jwu Jin Khong; Peter Anderson; Timothy L Gray; Michael Hammerton; Dinesh Selva; David David Journal: Ophthalmology Date: 2006-02 Impact factor: 12.079
Authors: Stéphane Abramowicz; Philippine Delvaulx; Martina Maria Delle Fave; Pauline Le Roux; Déborah Buisseret; Lavinia Postolache Journal: Case Rep Ophthalmol Date: 2022-04-22
Authors: Sohaib R Rufai; Noor Ul Owase Jeelani; Richard Bowman; Catey Bunce; Frank A Proudlock; Irene Gottlob Journal: BMJ Open Date: 2022-01-11 Impact factor: 2.692
Authors: Parinaz Rostamzad; Zehra F Arslan; Irene M J Mathijssen; Maarten J Koudstaal; Mieke M Pleumeekers; Sarah L Versnel; Sjoukje E Loudon Journal: J Clin Med Date: 2022-02-18 Impact factor: 4.241
Authors: Sohaib R Rufai; Richard Bowman; Catey Bunce; Vasiliki Panteli; Rebecca J McLean; Seema Teli; Irene Gottlob; Mervyn G Thomas; Noor Ul Owase Jeelani; Frank A Proudlock Journal: Transl Vis Sci Technol Date: 2021-07-01 Impact factor: 3.283